🏛️ Verified NIH Record • Updated 2026-05-01
The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis (NCT06928246)
Pilot Study on Cellular and Molecular Impact of Neuroimmune Interactions in Atopic Dermatitis
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Daniel Kaplan
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to understand cellular and molecular interactions in the skin of participants with mild-to-moderate AD, and how botulinum toxin alters these interactions.
Who can join: Review the eligibility criteria below.
Location: University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- UPMC Department of Dermatology — Pittsburgh, Pennsylvania
📞 Contact the Study Coordinator
Phone: (412) 647-2013
Email: ruhlcl@upmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atopic Dermatitis (AD)
- Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes — Edmonton, Alberta
- A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis — Phoenix, Arizona
- Moisturization and Skin Hydration Study — Vancouver, British Columbia
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis — Fargo, North Dakota
- Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population — Aguascalientes, Aguascalientes
Explore by condition: All Atopic Dermatitis (AD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.